pf-06863135
pfizer
['magnetismm-9', 'multiplemyeloma', 'tps8068', 'pfizer']
see more at #asco22 about the ongoing phase 1/2 magnetismm-9 study evaluating a step-up priming regimen and longer treatment interval of a bcma-cd3 bispecific antibody monotherapy in patients with r/r #multiplemyeloma tps8068 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ